Lotus Pharmaceutical (1795 TT) Growth Story for Blood Cancer Drugs
Lotus’ profits will remain upbeat thanks to stable market share for its main product Suboxone and its anti-obesity drug business in South Korea....
293 Views
Sign in with Google
ENTITY
SMARTSCORE: 3.2/5
Lotus Pharmaceutical (1795 TT)
Lotus Pharmaceutical (1795 TT)
28
Analysis
Health Care • Taiwan
Lotus Pharmaceutical Co., Ltd. manufactures and distributes oral medicine, ointment and injection medicine.
morex